Cargando…

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA

Detalles Bibliográficos
Autores principales:	Japzon, Nicole, Khwaja, Jahanzaib, Gabriel, Maria, Raju, Kavin, Rajaratnam, Vijith, Rismani, Ali, Kyriakou, Charalampia, D’sa, Shirley
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428973/ http://dx.doi.org/10.1097/01.HS9.0000976892.52239.81

Ejemplares similares

Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Systematic literature review of quality‐of‐life questionnaires in Waldenström macroglobulinaemia—need for a disease‐specific tool
por: Bristogiannis, Sotirios, et al.
Publicado: (2023)

Patient reported outcome measures in Waldenström macroglobulinaemia: A real‐world data analysis from the WMUK Rory Morrison Registry
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

P1150: REAL WORLD DATA ON BORTEZOMIB-BASED THERAPY IN WALDENSTRÖM’S MACROGLOBULINAEMIA: EFFECTIVE EVEN IN MULTIPLY TREATED PATIENTS INCLUDING PRIOR BTK-INHIBITORS
por: Uppal, E., et al.
Publicado: (2022)

PB2561: DEVELOPMENT OF COLD AGGLUTININ AUTOIMMUNE HEMOLYTIC ANEMIA DURING TREATMENT FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT.
por: Haddad, Nabila, et al.
Publicado: (2023)

P1112: TREATING BING-NEEL SYNDROME USING A TAILORED APPROACH: EXPERIENCE OF A SPECIALIST NEUROHAEMATOLOGY CLINIC
por: Khwaja, J., et al.
Publicado: (2022)

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION
por: Sridhar, Amrutha, et al.
Publicado: (2023)

Successful Treatment of Cryoglobulinaemia with Rituximab
por: Choudhry, M., et al.
Publicado: (2012)

PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE IN 653 PATIENTS.
por: Kanellias, Nikolaos, et al.
Publicado: (2023)

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

P1149: THE EVOLVING STATE OF PLAY IN 1000 PATIENTS WITH WALDENSTRÖM’S MACROGLOBULINAEMIA IN THE UNITED KINGDOM (UK): A REAL-WORLD DATA ANALYSIS FROM THE WMUK RORY MORRISON REGISTRY PROJECT
por: Uppal, E., et al.
Publicado: (2022)

2549 Characterizing the expression kinetics of HIV-1 envelope protein
por: Oh, Djin-Ye, et al.
Publicado: (2018)

IgM monoclonal gammopathies of clinical significance: diagnosis and management
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia
por: Mannu, Gurdeep Singh
Publicado: (2010)

54. Type I cryoglobulinaemia: vascular occlusion and thrombosis
por: Zacharias, Hannah, et al.
Publicado: (2018)

2549. Variance Between Clinicians and Guidelines in Management of HIV/HCV Coinfection
por: Naggie, Susanna, et al.
Publicado: (2019)

PB2156: ANALYSIS OF POSSIBLE CLONAL ORIGIN OF LARGE B-CELL DIFFUSED LYMPHOMAS ARISING IN PATIENTS WITH PRE-EXISTING HODGKIN’S LYMPHOMA
por: Masciopinto, P., et al.
Publicado: (2022)

A Case of Cutaneous Vasculitis with Underlying Hepatitis C and Cryoglobulinaemia
por: Groves, Cheryl, et al.
Publicado: (2008)

Spinal disease in myeloma: cohort analysis at a specialist spinal surgery centre indicates benefit of early surgical augmentation or bracing
por: Malhotra, Karan, et al.
Publicado: (2016)

Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up
por: Röth, Alexander, et al.
Publicado: (2023)

P1486: SERUM BIOMARKERS AS PREDICTORS OF RESPONSE TO SUTIMLIMAB IN COLD AGGLUTININ DISEASE (CAD): A POST-HOC ANALYSIS OF PHASE 3 CARDINAL AND CADENZA STUDY DATA
por: Barcellini, Wilma, et al.
Publicado: (2023)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Gaudêncio, Margarida, et al.
Publicado: (2021)

Cold Agglutinin Disease
por: Gabbard, Amy P., et al.
Publicado: (2020)

Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
por: Röth, Alexander, et al.
Publicado: (2022)

PB1716: COMPARISON BETWEEN CONVENTIONAL KARYOTYPING AND INTERPHASE FISH ON AIR-DRIED SMEARS IN EVALUATING STRUCTURAL CHROMOSOMAL ABNORMALITIES AMONG PEDIATRIC ACUTE LEUKEMIA PATIENTS
por: Bommannan, Karthik, et al.
Publicado: (2023)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

PB1952: CLL IN AYA
por: Mohamed, Shehab, et al.
Publicado: (2023)

PB1941: MIND-BODY INTERVENTION PROLONGS LYMPHOCYTE DOUBLING TIME AND TREATMENT-FREE SURVIVAL IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
por: Shapira, Shirley, et al.
Publicado: (2023)

The Association Analysis of Vascular Endothelial Growth Factor -2549 Insertion/ Deletion Variant and Endometriosis Risk
por: Sarhangi, Negar, et al.
Publicado: (2019)

Fibrillary comma-shaped electron-dense organized glomerular deposits associated with cryoglobulinaemia
por: Stabellini, Nevio, et al.
Publicado: (2008)

Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients
por: Coliche, Vladimir, et al.
Publicado: (2018)

AZD-1222/tozinameran: Flares of mixed cryoglobulinaemia vasculitis: 6 case reports
Publicado: (2022)

PB2120: HIV AND MALIGNANT HEMOPATHIES
por: Khibri, H., et al.
Publicado: (2022)

PB2564: COVID-19 AND FERRITIN
por: Kuiavovych, Bohdana, et al.
Publicado: (2023)

PB1757: VARIANT PHILADELPHIA CHROMOSOME IN ALL
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

PB2306: RELAPSE OF IMMUNE THROMBOCYTOPENIA AND MYOCARDITIS
por: Kapsouli, F., et al.
Publicado: (2022)

PB2322: TTP AFTER COVID 19
por: Gagloeva, D., et al.
Publicado: (2022)

PB1891: VARIANT PHILADELPHIA CHROMOSOME IN CML
por: Bouayed Abdelmoula, N., et al.
Publicado: (2022)

PB1827: ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
por: Marques, I., et al.
Publicado: (2022)

PB2363: REPORTING LANGUAGE IN HAEMATOLOGICAL MALIGNANCIES
por: Watt, S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6akgg6q59jg1dh7egvhbbmj8il